Absci (ABSI) Common Equity (2020 - 2026)
Absci (ABSI) reported Common Equity of $246.13 million for Q2 2026, up 42.0% from $173.37 million a year earlier and up 43.1% from the prior quarter.
Powered by 
Analysis
Absci (ABSI) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Absci posted Common Equity of $189.45 million, up 5.8% from FY2024.
- By year, Common Equity came in at $179.13 million in FY2024 (+1.7%), $176.18 million in FY2023 (-35.8%), $274.41 million in FY2022 (-25.0%) and $366.11 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Common Equity since Q1 2023.
- Year over year, Common Equity gained in five of the last eight quarters, with growth averaging 0.5%.
- The high point for year-over-year Common Equity in five years was Q2 2026 (growth of 42.0%); the low point was Q4 2023 (a decline of 35.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $171.97 million (Q1 2026), $189.45 million (Q4 2025) and $210.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,147.32 Bn | 1,115.91 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 622.12 Bn | 540.65 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 508.92 Bn | 482.03 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 365.47 Bn | 319.85 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 297.42 Bn | 261.41 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.39 Bn | 235.08 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 235.14 Bn | 190.54 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 193.77 Bn | 167.97 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Absci | 1.42 Bn | 792.06 Mn | - | 246.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 246.13 Mn |
| Mar 31, 2026 | 171.97 Mn |
| Dec 31, 2025 | 189.45 Mn |
| Sep 30, 2025 | 210.34 Mn |
| Jun 30, 2025 | 173.37 Mn |
| Mar 31, 2025 | 198.80 Mn |
| Dec 31, 2024 | 179.13 Mn |
| Sep 30, 2024 | 201.34 Mn |
| Jun 30, 2024 | 221.49 Mn |
| Mar 31, 2024 | 240.11 Mn |
| Dec 31, 2023 | 176.18 Mn |
| Sep 30, 2023 | 196.42 Mn |
| Jun 30, 2023 | 215.40 Mn |
| Mar 31, 2023 | 253.97 Mn |
| Dec 31, 2022 | 274.41 Mn |
| Sep 30, 2022 | 292.94 Mn |
| Jun 30, 2022 | 316.19 Mn |
| Mar 31, 2022 | 340.50 Mn |
| Dec 31, 2021 | 366.11 Mn |
| Sep 30, 2021 | 388.01 Mn |
API Access
Absci Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ABSI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ABSI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ABSI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();